Spandidos Publications style
Gao F, Wang F, Liu R, Xue F, Zhang J, Xu G, Bi J, Meng Z and Huo R: [Retracted] Epigenetic silencing of miR‑130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling. Int J Oncol 57: 1383-1383, 2020
APA
Gao, F., Wang, F., Liu, R., Xue, F., Zhang, J., Xu, G. ... Huo, R. (2020). [Retracted] Epigenetic silencing of miR‑130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling. International Journal of Oncology, 57, 1383-1383. https://doi.org/10.3892/ijo.2020.5136
MLA
Gao, F., Wang, F., Liu, R., Xue, F., Zhang, J., Xu, G., Bi, J., Meng, Z., Huo, R."[Retracted] Epigenetic silencing of miR‑130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling". International Journal of Oncology 57.6 (2020): 1383-1383.
Chicago
Gao, F., Wang, F., Liu, R., Xue, F., Zhang, J., Xu, G., Bi, J., Meng, Z., Huo, R."[Retracted] Epigenetic silencing of miR‑130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling". International Journal of Oncology 57, no. 6 (2020): 1383-1383. https://doi.org/10.3892/ijo.2020.5136